These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 39104319)

  • 21. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix abnormalities in pulmonary fibrosis.
    Upagupta C; Shimbori C; Alsilmi R; Kolb M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron-laden macrophage-mediated paracrine profibrotic signaling induces lung fibroblast activation.
    Li Y; Du X; Hu Y; Wang D; Duan L; Zhang H; Zhang R; Xu Y; Zhou R; Zhang X; Zhang M; Liu J; Lv Z; Chen Y; Wang W; Sun Y; Cui Y
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C979-C993. PubMed ID: 39183565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrotic extracellular matrix activates a profibrotic positive feedback loop.
    Parker MW; Rossi D; Peterson M; Smith K; Sikström K; White ES; Connett JE; Henke CA; Larsson O; Bitterman PB
    J Clin Invest; 2014 Apr; 124(4):1622-35. PubMed ID: 24590289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
    Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
    Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.
    Monaghan-Benson E; Wittchen ES; Doerschuk CM; Burridge K
    Mol Biol Cell; 2018 Sep; 29(18):2165-2175. PubMed ID: 29995590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis.
    Yao L; Zhou Y; Li J; Wickens L; Conforti F; Rattu A; Ibrahim FM; Alzetani A; Marshall BG; Fletcher SV; Hancock D; Wallis T; Downward J; Ewing RM; Richeldi L; Skipp P; Davies DE; Jones MG; Wang Y
    J Biol Chem; 2021 Sep; 297(3):101096. PubMed ID: 34418430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options.
    Hewitt RJ; Maher TM
    Drugs Aging; 2019 Jun; 36(6):485-492. PubMed ID: 30864023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-β/p38/ATF1 signaling pathway.
    Wei YQ; Guo YF; Yang SM; Ma HH; Li J
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6252-6261. PubMed ID: 32572892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.
    Aschner Y; Nelson M; Brenner M; Roybal H; Beke K; Meador C; Foster D; Correll KA; Reynolds PR; Anderson K; Redente EF; Matsuda J; Riches DWH; Groshong SD; Pozzi A; Sap J; Wang Q; Rajshankar D; McCulloch CAG; Zemans RL; Downey GP
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L294-L311. PubMed ID: 32491951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Mechanisms for the Antifibrotic Action of Nintedanib.
    Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.